Diligence memo · auto-generated · as of July 2, 2026
Palo Alto Health Sciences, Inc.
Palo Alto Health Sciences, Inc. looks fair against its niche peers and is quiet on financing cadence.
Businessfiled
Palo Alto Health Sciences, Inc. operates in Healthtech, based in KIRKLAND.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Palo Alto Health Sciences, Inc. has raised $50M in disclosed capital across 7 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $23M on 2024-04-01.
Most recent recorded round closed around 2024-04-01.
Valuation (modeled)modeled
Provath models Palo Alto Health Sciences, Inc. at approximately $166M (range $53M–$312M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.01× the median modeled value of Series B Healthtech companies in 2022–2024 (98 peers) — value vs value, same stage and era. Within the normal band (101% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 16 months.
Last raise 2.3 yr ago; this sector typically re-raises about every 14 months.
Slightly overdue versus sector cadence.
The last round stepped up 2.5× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 91% of Healthtech peers (2138 compared).
Modeled value ranks above 84% of those peers.
Closest niche peers: Casana Care, Inc., Mendel Health Inc., Bicycle Health Inc., Brave Health, Inc., Flume Health, Inc..
Peoplefiled
15 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.